Resultados de búsqueda - Aaron Etra
- Mostrando 1 - 4 Resultados de 4
-
1
Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD por Yu Akahoshi, Nikolaos Spyrou, William J. Hogan, Francis Ayuk, Zachariah DeFilipp, Daniela Weber, Hannah Choe, Elizabeth O. Hexner, Wolf Rösler, Aaron Etra, Karamjeet S. Sandhu, Gregory A. Yanik, Chantiya Chanswangphuwana, Carrie L. Kitko, Ran Reshef, Sabrina Kraus, Matthias Wölfl, Matthias Eder, Hannah Bertrand, Muna Qayed, Pietro Merli, Stephan A. Grupp, Paibel Aguayo‐Hiraldo, Tal Schechter, Evelyn Ullrich, Janna Baez, Rahnuma Beheshti, Sigrun Gleich, Steven Kowalyk, George Morales, Rachel Young, Deukwoo Kwon, Ryotaro Nakamura, John E. Levine, James L.M. Ferrara, Yi‐Bin Chen
Publicado 2023Artigo -
2
MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD por Hannah Major-Monfried, Anne S. Renteria, Attaphol Pawarode, Pavan Reddy, Francis Ayuk, Ernst Holler, Yvonne A. Efebera, William J. Hogan, Matthias Wölfl, Muna Qayed, Elizabeth O. Hexner, Kitsada Wudhikarn, Rainer Ordemann, Rachel Young, Jay Shah, Matthew J. Hartwell, Mohammed S. Chaudhry, Mina Aziz, Aaron Etra, Gregory A. Yanik, Nicolaus Kröger, Daniela Weber, Yi‐Bin Chen, Ryotaro Nakamura, Wolf Rösler, Carrie L. Kitko, Andrew C. Harris, Michael A. Pulsipher, Ran Reshef, Steven Kowalyk, George Morales, I.M. Torres, Umut Özbek, James L.M. Ferrara, John E. Levine
Publicado 2018Artigo -
3
The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease por Hrishikesh K. Srinagesh, Umut Özbek, Urvi Kapoor, Francis Ayuk, Mina Aziz, Kaitlyn Ben-David, Hannah Choe, Zachariah DeFilipp, Aaron Etra, Stephan A. Grupp, Matthew J. Hartwell, Elizabeth O. Hexner, William J. Hogan, Alexander B. Karol, Stelios Kasikis, Carrie L. Kitko, Steven Kowalyk, Jung‐Yi Lin, Hannah Major-Monfried, Stephan Mielke, Pietro Merli, George Morales, Rainer Ordemann, Michael A. Pulsipher, Muna Qayed, Pavan Reddy, Ran Reshef, Wolf Rösler, Karamjeet S. Sandhu, Tal Schechter, Jay Shah, Keith Sigel, Daniela Weber, Matthias Wölfl, Kitsada Wudhikarn, Rachel Young, John E. Levine, James L.M. Ferrara
Publicado 2019Artigo -
4
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease por Monzr M. Al Malki, Kaitlyn London, Janna Baez, Yu Akahoshi, William J. Hogan, Aaron Etra, Hannah Choe, Elizabeth O. Hexner, Amelia Langston, Sunil Abhyankar, Doris M. Ponce, Zachariah DeFilipp, Carrie L. Kitko, Kehinde Adekola, Ran Reshef, Francis Ayuk, Alexandra Capellini, Chantiya Chanswangphuwana, Matthias Eder, Gilbert Eng, Isha Gandhi, Stephan A. Grupp, Sigrun Gleich, Ernst Holler, Nóra Rebeka Jávorniczky, Stelios Kasikis, Steven Kowalyk, George Morales, Umut Özbek, Wolf Rösler, Nikolaos Spyrou, Gregory A. Yanik, Rachel Young, Yi‐Bin Chen, Ryotaro Nakamura, James L.M. Ferrara, John E. Levine
Publicado 2023Artigo
Herramientas de búsqueda:
Materias Relacionadas
Disease
Internal medicine
Medicine
Biochemistry
Biomarker
Immunology
Biology
Graft-versus-host disease
Oncology
Physics
Adverse effect
Algorithm
Chemistry
Chemotherapy
Clinical trial
Computer science
Corticosteroid
Cumulative incidence
Cyclophosphamide
Gastroenterology
Gastrointestinal tract
Hematopoietic stem cell transplantation
Incidence (geometry)
Inflammatory bowel disease
MAGIC (telescope)
Natalizumab
Optics
Quantum mechanics
Transplantation